BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19642024)

  • 1. BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.
    Schmidt AL; de Farias CB; Abujamra AL; Kapczinski F; Schwartsmann G; Brunetto AL; Roesler R
    J Mol Neurosci; 2010 Mar; 40(3):303-10. PubMed ID: 19642024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer.
    Brunetto de Farias C; Rosemberg DB; Heinen TE; Koehler-Santos P; Abujamra AL; Kapczinski F; Brunetto AL; Ashton-Prolla P; Meurer L; Reis Bogo M; Damin DC; Schwartsmann G; Roesler R
    Oncology; 2010; 79(5-6):430-9. PubMed ID: 21474968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cells.
    Cornelio DB; DE Farias CB; Prusch DS; Heinen TE; Dos Santos RP; Abujamra AL; Schwartsmann G; Roesler R
    Mol Clin Oncol; 2013 Jan; 1(1):148-152. PubMed ID: 24649138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrin-releasing peptide signaling plays a limited and subtle role in amygdala physiology and aversive memory.
    Chaperon F; Fendt M; Kelly PH; Lingenhoehl K; Mosbacher J; Olpe HR; Schmid P; Sturchler C; McAllister KH; van der Putten PH; Gee CE
    PLoS One; 2012; 7(4):e34963. PubMed ID: 22509372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
    Jaeger M; Ghisleni EC; Fratini L; Brunetto AL; Gregianin LJ; Brunetto AT; Schwartsmann G; de Farias CB; Roesler R
    Childs Nerv Syst; 2016 Jan; 32(1):61-4. PubMed ID: 26590027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrin-releasing peptide receptors regulate proliferation of C6 Glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism.
    Flores DG; de Farias CB; Leites J; de Oliveira MS; Lima RC; Tamajusuku AS; Di Leone LP; Meurer L; Brunetto AL; Schwartsmann G; Lenz G; Roesler R
    Curr Neurovasc Res; 2008 May; 5(2):99-105. PubMed ID: 18473825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice.
    Matsumoto Y; Yokoi H; Kimura T; Matsumoto Y; Kawada M; Arae K; Nakae S; Ikeda T; Matsumoto K; Sakurai H; Saito K
    Laryngoscope; 2018 Nov; 128(11):E377-E384. PubMed ID: 30151920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts.
    Schroeder RP; de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Breeman WA; Krenning EP; de Jong M
    Int J Cancer; 2010 Jun; 126(12):2826-34. PubMed ID: 19876914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.
    Reubi JC; Fleischmann A; Waser B; Rehmann R
    Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.
    Goldhoff P; Warrington NM; Limbrick DD; Hope A; Woerner BM; Jackson E; Perry A; Piwnica-Worms D; Rubin JB
    Clin Cancer Res; 2008 Dec; 14(23):7717-25. PubMed ID: 19047098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling.
    Farias CB; Lima RC; Lima LO; Flores DG; Meurer L; Brunetto AL; Schwartsmann G; Roesler R
    Oncology; 2008; 75(1-2):27-31. PubMed ID: 18719351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.
    Lango MN; Dyer KF; Lui VW; Gooding WE; Gubish C; Siegfried JM; Grandis JR
    J Natl Cancer Inst; 2002 Mar; 94(5):375-83. PubMed ID: 11880476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide.
    Tokita K; Hocart SJ; Coy DH; Jensen RT
    Mol Pharmacol; 2002 Jun; 61(6):1435-43. PubMed ID: 12021405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
    Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
    Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of internalization and recycling of the gastrin releasing peptide receptor-green fluorescent protein chimera expressed in epithelial cells.
    Slice LW; Yee HF; Walsh JH
    Recept Channels; 1998; 6(3):201-12. PubMed ID: 10100328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone deacetylase inhibitor sodium butyrate in combination with brain-derived neurotrophic factor reduces the viability of DAOY human medulloblastoma cells.
    Nör C; de Farias CB; Abujamra AL; Schwartsmann G; Brunetto AL; Roesler R
    Childs Nerv Syst; 2011 Jun; 27(6):897-901. PubMed ID: 21560052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
    Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
    Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats.
    Kauer-Sant'Anna M; Andreazza AC; Valvassori SS; Martins MR; Barbosa LM; Schwartsmann G; Roesler R; Quevedo J; Kapczinski F
    Peptides; 2007 Jul; 28(7):1447-52. PubMed ID: 17629354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
    Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
    Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.
    Sun B; Schally AV; Halmos G
    Regul Pept; 2000 Jun; 90(1-3):77-84. PubMed ID: 10828496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.